Table 3. Proteomic and transcriptomic changes of the spots that changed significantly in the proteomic analysis of CMA-treated HeLa cells.
Protein name | GENE | Proteomic changes |
Transcriptomic changes |
Remarks | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Spot no | CMA | Dp44mT | CMA | Dp44mT | |||||||
Adenylyl cyclase-associated protein 1 | CAP1 | 1137 | 0.54 | *** | 0.76 | ** | 1.05 | 1.34 | |||
Annexin A1 | ANXA1 | 1491 | 1.14 | ** | 1.12 | ** | 2.88 | 2.77 | |||
ATP-dependent RNA helicase DDX3X | DDX3X | 2064 | 1.23 | ** | 1.20 | ** | 0.97 | 1.06 | |||
Cytoplasmic aconitate hydratase | ACO1 | 662 | 1.32 | *** | 1.09 | 1.21 | 0.99 | Iron | |||
Dihydropyrimidinase-related protein 3 | DPYSL3 | 890 | 1.48 | ** | 1.12 | 0.91 | 0.92 | ||||
DNA polymerase subunit delta 2 | POLD2 | 1237 | 1.25 | ** | 1.08 | 0.74 | 0.70 | ||||
Elongation factor 1-beta | EEF1B2 | 2039 | 0.85 | * | 0.98 | 0.90 | 0.94 | ||||
Elongation factor 1-delta | EEF1D | 1556 | 1.20 | *** | 1.19 | *** | 0.99 | 0.99 | |||
Elongation factor 2 | EEF2 | 643 | 1.87 | *** | 1.12 | 1.05 | 1.00 | ||||
657 | 0.75 | ** | 0.53 | *** | |||||||
Fructose-bisphosphate aldolase A | ALDOA | 2091 | 1.44 | *** | 1.28 | ** | 1.78 | 1.52 | Glycolysis | ||
2132 | 1.27 | *** | 1.34 | *** | |||||||
Guanine nucleotide-binding protein subunit beta 2-like 1 | GNB2L1 | 1627 | 0.76 | *** | 0.76 | *** | 0.71 | 0.70 | |||
Heat shock cognate 71 kDa protein | HSPA8 | 1980 | 0.73 | *** | 0.91 | . | 0.49 | 0.73 | |||
Heat-shock protein beta-1 | HSPB1 | 1764 | 0.72 | *** | 0.84 | *** | 0.74 | 0.79 | |||
2212 | 0.72 | *** | 0.77 | *** | |||||||
Inosine-5′-monophosphate dehydrogenase 2 | IMPDH2 | 2150 | 0.76 | ** | 0.87 | * | 0.78 | 0.49 | |||
Nucleophosmin | NPM1 | 2026 | 0.51 | *** | 0.84 | * | 0.84 | 0.76 | |||
Peroxiredoxin-2 | PRDX2 | 1857 | 1.23 | *** | 1.20 | *** | 1.27 | 1.20 | |||
Peroxiredoxin-6 | PRDX6 | 1762 | 0.69 | *** | 0.90 | ** | 0.61 | 0.57 | |||
Phosphoglycerate kinase 1 | PGK1 | 1373 | 1.63 | *** | 1.41 | *** | 2.78 | 2.37 | Glycolysis | ||
Phosphoglycerate mutase 1 | PGAM1 | 1745 | 1.39 | *** | 1.29 | ** | 1.39 | 1.57 | Glycolysis | ||
Prelamin-A/C | LMNA | 840 | 1.37 | *** | 1.46 | *** | 1.30 | 1.22 | |||
845 | 1.65 | *** | 1.35 | *** | |||||||
851 | 1.82 | *** | 1.50 | *** | |||||||
2072 | 1.32 | *** | 1.06 | ||||||||
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 | PLOD2 | 633 | 3.25 | *** | 2.78 | *** | 5.55 | 3.13 | Iron | ||
Prohibitin | PHB | 1668 | 0.85 | ** | 0.95 | 0.52 | 0.48 | ||||
Prolyl 4-hydroxylase subunit alpha-1 | P4HA1 | 1049 | 2.79 | *** | 2.63 | *** | 3.21 | 2.08 | Iron | ||
RNA-binding protein 4B | RBM4B | 1438 | 1.33 | *** | 1.19 | ** | 0.95 | 0.77 | |||
Stress-induced-phosphoprotein 1 | STIP1 | 1011 | 0.79 | ** | 0.97 | 0.67 | 0.66 | ||||
Triosephosphate isomerase | TPI1 | 1786 | 1.47 | *** | 1.30 | ** | 1.69 | 1.27 | Glycolysis |
In proteomic changes, the mean ratios of identified spots between control and compound-treated cells are listed. Non-repeated-measures ANOVA and Dunnett’s test for post hoc analysis were performed. In transcriptomic changes, the ratio between control and compound–treated cells are listed. If there are more than one probes corresponding to the protein, the mean ratio was calculated. *P < 0.05; **P < 0.01; ***P < 0.001.